Final reminder; less than 30 days to The International Liver CongressTM 2017

March 29, 2017

With less than 30 days to go until The International Liver CongressTM 2017, it's time to register as a member of the press to attend the congress!

The official press programme is now available online, which includes details of the press conferences and abstracts that will be presented as part of the press programme, so that you can begin planning your attendance! The programme is available here: https://ilc-congress.eu/pressprogramme/

The 52nd Annual Congress of The European Association for the Study of the Liver (EASL), is being held from 19-23 April, at the RAI Congress Centre, Amsterdam, The Netherlands. Ground-breaking data will be presented at three official press conferences, there will be an on-site press centre and private rooms available for conducting interviews with key speakers and EASL Governing Board members.

Don't miss the chance to attend the biggest hepatology event in Europe - media registration is open and free of charge, so e-mail the ILC Press Office now to obtain your personalised press registration code and register online today! Please ensure you are able to provide a valid press card or formal journalist credentials.

The International Liver CongressTM is a multi-disciplinary scientific event which attracts over 10,000 delegates from around the world every year. Our aim is to showcase the latest advances in hepatology and unveil a wide variety of new, innovative data to improve the management of liver disease.
-end-
The ILC Press Office Team is available to answer any questions you may have and can be contacted at: ILCpressoffice@ruderfinn.co.uk. Further information on media registration can be found here: http://ilc-congress.eu/media-registration/.

We look forward to welcoming you in Amsterdam!

European Association for the Study of the Liver

Related Liver Articles from Brightsurf:

Eating less suppresses liver cancer due to fatty liver
Liver cancer from too much fat accumulation in the liver has been increasing in many countries including Japan.

When liver cirrhosis is deadly
A study by an international team of researchers headed by Professor Jonel Trebicka from the Frankfurt University Hospital and funded by the foundation EF Clif, has discovered which patients are particularly at risk for acute-on-chronic liver failure.

Fatty liver disease is underdiagnosed in the US
According to an analysis published in Alimentary Pharmacology & Therapeutics, nonalcoholic fatty liver disease (NAFLD) is grossly underdiagnosed in the United States.

A new treatment for liver cancer
In the latest issue of Molecular Therapy, Skoltech and MIT researchers have published a new combinatorial therapy for the treatment of liver cancer.

Longevity protein SIRT6 also protects against fatty liver and fatty liver disease
SIRT6 regulates fat metabolism by activating another protein called peroxisome proliferator-activated receptor alpha (PPAR-alpha).

Immune cell identity crisis: What makes a liver macrophage a liver macrophage?
UC San Diego researchers investigated how a type of immune cell called a macrophage becomes specialized to the liver.

Liver transplants could be redundant with discovery of new liver cell
Researchers at King's College London have used single cell RNA sequencing to identify a type of cell that may be able to regenerate liver tissue, treating liver failure without the need for transplants.

How viable is your liver after you die?
In a paper to be published in a forthcoming issue of TECHNOLOGY, a group of researchers from Harvard Medical School have done a study on the viability of donated livers and its correlation with donor demographics.

Blocking platelets: A possible option to prevent fatty liver disease and liver cancer
Blood platelets which interact with liver cells and immune cells play a major role in the development of fatty liver disease, non-alcoholic fatty liver inflammation and liver cancer, scientists from the German Cancer Research Center (DKFZ) in Heidelberg and from Zurich University and University Hospital have now shown in a publication.

Micro-control of liver metabolism
A new discovery has shed light on small RNAs called microRNAs in the liver that regulate fat and glucose metabolism.

Read More: Liver News and Liver Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.